Zacks Investment Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Zacks Investment Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-100,000	Closed	-$926K	–	608
2020 Q1	$926K	Sell	100,000 -16,566	-14%	-$231K	0.02%	308
2019 Q4	$1.94M	Buy	116,566 +22,157	+23%	+$359K	0.04%	273
2019 Q3	$1.57M	Buy	94,409 +69,322	+276%	+$959K	0.03%	311
2019 Q2	$345K	Buy	+25,087	New	+$384K	0.01%	479

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Zacks Investment Management's OXFD Position: Q2 2020 in Review

Zacks Investment Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2020, closing a stake of 100,000 shares — an estimated $926K sold.

Zacks Investment Management first reported a position in OXFD in Q2 2019 and held it in 4 quarters. The position peaked at $1.94M in Q4 2019. 65 funds tracked by Wall St. Rank hold OXFD as of Q2 2020.

Zacks Investment Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2020 after selling out during the quarter.
Zacks Investment Management sold 100,000 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2020, an estimated $926K.
Zacks Investment Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2019 and held it in 4 quarters.
Zacks Investment Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1.94M in Q4 2019.
65 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2020.

Based on Zacks Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.